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Background: Elcatonin (ECT) is used to prevent and treat osteoporosis. However, little is known about its effect on
the disuse osteoporosis (DOP). The aim of this study is to evaluate the effect of ECT on DOP caused by fracture
fixation.
Methods: Forty-five male Sprague-Dawley (SD) rats, aged 6 weeks, were randomly allocated into three groups: the
control group without surgery and elcatonin treatment (CTR, n = 15), the surgery group without elcatonin
treatment (SUR, n = 15), and the surgery group which received elcatonin subcutaneously (SUR + ECT, n = 15).
Surgery was produced by cutting the midshaft of the right femur transversely, fixing with stainless intramedullary
needle, and immobilizing the right leg. All the proximal tibias from the random five rats in each group were
harvested and investigated by evaluating bone mineral density (BMD), X-ray images, and histological staining
respectively at the 4th, 8th, and 12th weeks after surgery.
Results: Both of the SUR and SUR + ECT groups obviously exhibited lower BMD values compared to the CTR
group; however, the SUR + ECT group showed significantly higher BMD values (p < 0.001, p < 0.05, and p < 0.05)
than the SUR group at each time point after surgery. Moreover, similar changes were observed between these
groups when examining the radiographs and hematoxylin and eosin (HE) staining.
Conclusions: Elcatonin attenuates disuse osteoporosis after fractures in rats, which may provide a new avenue to
prevent and treat disuse osteoporosis after surgery in clinic.
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Disuse osteoporosis (DOP) is defined as localized or
generalized bone loss due to skeletal mechanical unload-
ing [1–3], such as long-term therapeutic bed rest [4],
immobilization due to motor paralysis from injury of the
central nervous system [5] or peripheral nerves, applica-
tion of cast to treat fractures [6], and prolonged weight-
lessness during spaceflight [7]. In clinic practice, DOP is
inevitable when plaster fixation is applied to stabilize
the fracture and immobilize the bones or joints after the
surgery [3, 6], which results in a decrease of bone
strength and an increased risk of secondary fracture.
Since the pathophysiology of DOP is still unclear, the
treatments, for instance, therapeutic exercise, electrical* Correspondence: bslan56@163.com
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quite satisfactory so far. However, it is reported that low
or loss of mechanical stress on bones induces acceleration
of osteoclast-mediated bone resorption and inhibition of
osteoblast-mediated bone formation and finally leads to
bone loss [1, 3, 8]. Therefore, anti-resorptive agents were
considered to prevent or treat DOP.
Elcatonin (ECT) is a physicochemically and biologic-
ally stable synthetic derivative of eel calcitonin and
which consists of 31 amino acids with stable ethylene
linkage as a result of substituting the intra-chain disul-
fide bond of calcitonin [9, 10]. It has been reported that
ECT suppresses bone resorption through direct action
on the calcitonin receptors of osteoclasts [11, 12] and
acts with potent analgesic effect [12–15]. Moreover, data
showed that ECT did not delay the overall fracture heal-
ing process compared to alendronate which strongly
suppressed callus remodeling in cynomolgus monkeysdistributed under the terms of the Creative Commons Attribution License
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used for the prophylaxis and treatment of osteoporosis
[14, 16, 17], but a beneficial effect of ECT on bone has
not been evaluated in surgically induced DOP yet.
Therefore, in the present study, we investigated the ef-
fects of the administration of elcatonin on the distal
bone away from the fracture fixation of femur in rats
which were rodent models of surgically-induced DOP.
Materials and methods
Animals
Fifty male Sprague-Dawley rats, aged 6 weeks in this
study, were provided by Laboratory Animal Center of
Xi’an Jiaotong University. All rats were housed individu-
ally in cages in a standard animal room maintained at a
temperature of 22 ± 3 °C, a humidity of 50 ± 20 %, and
a 12-h light-dark cycle, and ventilated ten or more times
per hour. The animals were allowed access to food and
tap water ad libitum during the entire experiment
period. All animal procedures were conducted in accord-
ance with the Principles of Laboratory Animal Care
established by National Institutes of Health (NIH) and
guidelines from Laboratory Animal Care Committee of
Xi’an Jiaotong University.
Besides the five rats that were harvested and followed
by histological staining procedure before surgery, other
45 animals were randomly allocated into three groups
with 15 each: the control group without surgery and
ECT treatment (CTR), the surgery group without ECT
treatment (SUR), and the surgery group which received
ECT subcutaneously (SUR + ECT). Body weight of the
animals was recorded monthly. Surgery was conducted
after 3-day feeding by cutting the midshaft of the right
femur transversely, fixing with stainless intramedullary
needle, and immobilizing the right hind limb via tibia-
tail fixation. All the femurs, knee joints, and tibias
from the random five rats in each group were respect-
ively harvested at the 4th, 8th, and 12th weeks after
surgery, and the proximal tibias were investigated byFig. 1 A radiographic capture and a camera photo of rat after surgical pro
and the right hind limb was immobilized against the tail. b The rat can staevaluating bone mineral density (BMD), X-ray images,
and histological staining.
Establishment of the animal model
The surgeries including post-osteotomy fixation and
tibia-tail fixation were performed under anesthesia
with 10 % chloral hydrate administered at a dose of
50 mg/kg, intraperitoneally.
1) Post-osteotomy fixation: The osteotomy and fixation
were made in the right femur of each rat according
to the method of Mathavan et al. [18]. Under
standard sterile conditions, a lateral approach at the
middle of femur was made and the periosteum was
circumferentially incised. A transverse fracture was
performed at the middiaphysis with an oscillating
power saw, then the fracture site was stabilized and
fixed by an intramedullary steel needle with a
diameter of 1.2 mm (Fig. 1a). The incision was
precisely closed with sterilized sutures.
2) Tibia-tail fixation: After the femoral fracture and
internal fixation were accomplished, the right hind
limbs of animals in the SUR and SUR + ECT groups
were immobilized against the tails with simple
external fixation based on the operation previously
described by Zarzhevsky et al. [19]. Briefly, under
anesthesia, the right ankles of animals were drilled,
and a steel wire with diameter of 1.0 mm was
inserted and connected to the tail at a distance of
1.5 cm from the anus. All rats were able to stand
with their other three limbs after anesthesia
resuscitation (Fig. 1b). The wires were removed 8
weeks after the surgery in the SUR and SUR + ECT
groups. The external fixators were sterilized by
iodophors and checked daily.
ECT administration
Following the operations, ECT (Sidinuo, Luye Pharma
Group Co. Ltd., Shandong Province, China) wascedure. a The right femur was fractured and fixed with a steel needle,
nd and move with other three legs after analepsia
Fig. 2 Body weight changes in the model of disuse osteoporosis.
Data are expressed as mean ± SEM, n = 5. ***p < 0.001 versus the
CTR group at each time point as evaluated by ANOVA
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ECT group, subcutaneously for 12 weeks. The CTR and
SUR groups correspondingly administered the vehicles of
the ECT injections.
Evaluation methods
Bone samples from the right proximal tibias were subse-
quently evaluated via radiographic assessment, BMD
measurement, and histology.
Radiography
Antero-posterior radiographs were obtained from all
animals via a clinical X-ray system at a condition of
Voltage/Current = 52 kV/1.60 mA. The radiographs
from the proximal tibias were visually assessed for the
degrees of osteoporosis through double-blinded review-
ing by two orthopedic surgeons. Compared to the CTR
group, each bone from SUR or SUR + ECT group was
scored as 0 (almost similar density), 0.5 (mildly lower
density or thinner bone cortex), 1 (mildly lower density
and thinner bone cortex), or 2 (severely lower density
or/and thinner bone cortex).
BMD measurement
BMD value was measured for the proximal third of
right tibia which primarily consisted of cancellous
bone via dual-energy X-ray absorptiometry (DXA)
(Norland XR-46, Norland/Swissray, USA) at a scan
pitch of 1.5 mm and a scan speed of 60 mm/s.
Histology
Followed by tissue collection and decalcification with 10 %
EDTA for 3 weeks, the right tibias from all groups were
commenced with chemical fixation in 4 % formaldehyde
for 48 h. Subsequently, the samples were dehydrated in
graded ethanol, cleared in xylene, immerged in molten par-
affin at 60 °C overnight, and embedded into wax block.
Transverse sections of 4-μm thickness were cut by a micro-
tome (RM2125RT, Leica Biosystems Nussloch GmbH,
Germany) and stained with hematoxylin and eosin follow-
ing standard protocol. The areas of bone trabeculae were
quantified with Image-Pro Plus software (Version 6.0,
Media Cybernetics, Inc., USA). Quantitative scoring of
the histology was performed to determine the density
of cancellous bone. Two blinded independent re-
viewers performed the analysis of all samples and the
measurements were averaged.
Statistical analysis
Data were expressed as the mean ± standard error of the
mean (SEM). One-way ANOVA analysis was carried out
to analyze for differences among the groups by SPSS
(Version 22.0, SPSS/IBM Corporation, USA), and both
Tukey HSD and Bonferroni tests were applied as a posthoc test if statistical significance was determined. A
value of probability level (p) which was less than 0.05
was considered statistically significant.
Results
General condition
The animals survived well before harvesting, and no health
problems were pointed out during the study period. As
shown in Fig. 2, the body weight of rats in the CTR group
was increased more than that in either of the SUR and
SUR + ECT groups with obvious significant difference at
different time point, and there was no statistical difference
in the mean body weight between the SUR and SUR +
ECT groups. However, the body weight gains in the SUR
group was suppressed a bit than that in the SUR + ECT
group at the 4th, 8th, and 12th weeks after surgery.
Radiographic finding
Compared to the CTR group at each time point (Fig. 3),
both of SUR and SUR + ECT groups featured lower
density and thinner bone cortex in the tibias, but much
lower density and thinner bone cortex in the tibias in
the SUR group existed than those in the SUR + ECT
group. Moreover, compared to the SUR group, more
bony callus formation, faster fracture healing, and
higher density in the distal femur were observed in the
SUR + ECT group at different time point. The scores of
radiographs in the SUR group were significantly higher
(p < 0.01, p < 0.05, and p < 0.05) at the 4th, 8th, and
12th weeks after surgery, respectively, compared to the
SUR + ECT group (Fig. 4).
BMD measurement
In the SUR group, the BMD of proximal third of right
tibia was obviously reduced (p < 0.001, p < 0.01, and p <
0.001) at each time point when compared with that in
the CTR group (Fig. 5); and in particular, the BMD at
Fig. 3 Representative radiographs of the femurs and tibias in the CTR, SUR, and SUR + ECT groups are presented at the 4th, 8th, and 12th weeks
post-surgery, respectively
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and decreased even below the BMD before surgery. Fur-
thermore, in the SUR + ECT group, the BMD consider-
ably increased (p < 0.001, p < 0.05, and p < 0.05) in the
proximal third of right tibia when compared with that in
the SUR group at each time spot, and the BMD of the
proximal third was observed to be no significantly differ-
ent from that in the CTR group.
Histological scoring
Analysis of the histological staining and scoring rein-
forced the findings of radiography and BMD measure-
ment. As shown in Fig. 6, the bone trabeculae of the
proximal metaphysis of right tibias in the SUR group
were rare or vanished compared to the CTR group
at the 4th week after surgery, and gradually getting
more and better at the 8th and 12th weeks; however, theFig. 4 Radiographic scoring of osteoporosis in the proximal tibias by
visual assessment by two orthopedic surgeons. Data are expressed
as mean ± SEM, n = 5. #p < 0.05, ##p < 0.01 the SUR + ECT group
versus the SUR group at each time point as evaluated by ANOVASUR + ECT group exhibited much denser and better ar-
ranged trabeculae than the SUR group at each time
point and similar with the CTR group.
Moreover, according to the quantitative scoring of
histology (Fig. 7), all animals that suffered surgery
featured lower percentage of bone trabeculae during
the whole research period compared to those in the
CTR group except for the SUR + ECT group at the
4th week post-surgery. Additionally, the bone tra-
beculae were severely reduced in the SUR group at
the 4th and 8th weeks (p < 0.001, respectively) even
below the values of bone trabeculae at the 0th week,
and the SUR + ECT group showed slower increases
of bone trabeculae than the CTR group and signifi-
cant differences (p < 0.001, p < 0.01, and p < 0.001)
compared to the SUR group at each time point.Fig. 5 The BMDs of proximal third of right femurs in different
groups at the 0th, 4th, 8th, and 12th weeks after surgery. Data are
expressed as mean ± SEM, n = 5. **p < 0.01 and ***p < 0.001 versus
the CTR group; #p < 0.05 and ###p < 0.001 the SUR + ECT group
versus the SUR group at each time point as evaluated by ANOVA
Fig. 6 HE staining of proximal metaphysis of right tibia in the CTR, SUR, and SUR + ECT groups at the 4th, 8th, and 12th weeks post-surgery.
Histological images were taken at 40× magnification
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Using a well-established open rat model induced by
post-osteotomy fixation and tibia-tail immobilization,
our present study postulates and confirms the hypoth-
esis that the administration of ECT attenuates disuse
osteoporosis on the distal bone away from fracture fix-
ation in rats. It is known that ECT is presently used
worldwide for preventing and treating the osteoporosis,
however, we were the first to investigate the effects of
ECT on the post-surgery DOP, and three observations inFig. 7 Quantitative histological scores of bone trabeculae from the
proximal metaphysis of right tibia in the CTR, SUR, and SUR + ECT
groups at the 0th, 4th, 8th, and 12th weeks post-surgery. Data are
expressed as mean ± SEM, n = 5. **p < 0.01 and ***p < 0.001 versus
the CTR group; ###p < 0.001 the SUR + ECT group versus the SUR
group at each time point as evaluated by ANOVAparticular demonstrated that ECT notably suppressed
the bone loss at the 4th, 8th, and 12th weeks after sur-
gery. The first observation was in relation to radio-
graphic assessment where the SUR + ECT group
exhibited higher density and thicker bone cortex in the
proximal tibia compared to the SUR group. Radio-
graphic outcomes is advantageous only if it is matched
with BMD values, and this was substantiated with the
second observation from the BMD measures where the
values in the SUR + ECT group increased smoothly
along with the CTR group. And quantitative histology
showed an increased trabecular percentage in the SUR +
ECT group compared to that in the SUR group. Thus,
through manipulation of the anti-resorptive influences
of ECT on surgery-induced DOP, an effective anti-
osteoporosis outcome was achieved.
The technique of fracture fixation employed in our
study [18, 20] is analogous to a common clinical method
used in the treatment of femoral fractures, and the tibia-
tail fixation [19, 21] is applied for establishing a model
of unloading on the musculoskeletal system as the cast
immobilization after fracture surgery in clinic.
In addition, the concerns of anti-osteoporosis effects by
ECT have been interpreted in the literatures [9, 10, 22–24].
For instance, Iwamoto et al. presented data from a 5-year-
period study demonstrating a sustainable role of ECT in
post-menopausal women with osteoporosis [22]. In
addition, another study in post-menopausal osteoporotic
women confirmed the active effects of short-term
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lumbar BMD and bone turnover with back pain [23, 24].
Furthermore, mild suppression of callus remodeling by
ECT did not impair overall fracture healing process in the
femoral fracture model of cynomolgus monkeys [9],
whereas ECT facilitated osteoblast proliferation in the frac-
ture site and suppressed the systemic acceleration of bone
resorption without affecting cortical bone regeneration after
drill-hole injuries in mice [10]. According to the work
above, it was considered to study the influence of ECT
as an alternative chemical on the post-fracture DOP in
rats without delaying the fracture healing.
During the 12 weeks of treatment, a marked lower body
weight was observed both in the SUR and SUR + ECT
groups (Fig. 2), which interpreted that the administration
of ECT did not affect the weight changes of animals after
surgery as body weight is a general index of the health of
an animal [2]. And this might be attributed to a decrease
in food intake after surgery.
As the plain X-ray film reveals important features of
disuse osteoporosis affecting tubular bones, thinning of
cortices, increased radiolucency, and rarefication of
bone trabeculae [3, 18, 25], the potent anti-osteoporosis
effectiveness of ECT in sustaining the bony density were
clearly demonstrated in the results from the radio-
graphic analysis where the presence of ECT produced
less rarefication of bone in the proximal tibia at each
time point. Moreover, with the addition of ECT to the
animals after surgery, not only did the combination of
fracture reliably and quickly achieve union but also did
the features of bone substance in femurs attain nearly
on par with the non-operated control femurs at the
12th week post-surgery, which was in line with the con-
clusion described previously [10].
Since the technology of dual-energy X-ray absorpti-
ometry (DXA) has been used to measure regional
BMD [3] which has been described as a surrogate
measure of bone strength [26], BMD measurements
have developed and provided the basis for diagnosing
osteoporosis, predicting the risk of osteoporotic frac-
ture, and evaluating the therapeutic effects of drugs
[27]. In our study, the BMDs in the proximal third of
tibia from the SUR group at the 4th, 8th, and 12th
weeks were all much lower than those in the normal rat,
at the same time, it was observed that the therapy with
ECT could increase the BMDs to a statistically undiffer-
entiated level as the CTR group. In particular, the BMD
values in the proximal third of tibia from non-ECT-
treated rats went down dramatically at the 4th week
after the fracture operation and tibia-tail fixation. This in-
dicates that the administration of ECT we used in present
study can suppress the surgically-induced DOP effectively
both in the former 8 weeks with immobilization and in
the later 4 weeks without.Similar to our observations above, histological staining
and analysis of the metaphysis from ECT-treated tibias con-
firmed significant increases in the quantitative trabeculae at
the 4th, 8th, and 12th weeks after surgery compared to the
SUR group. Under the circumstance of immobilization, the
osteoclast activities increased because of the decreased
mechanical stimulus [2]. Although its precise physiological
role in the rats is not well understood, so far it is known
that ECT inhibits bone resorption by binding to the
calcitonin-like receptors on the osteoclast membrane, thus,
destroying osteoclast activities [12, 28]. Based on our find-
ings, we speculate that ECT might suppress osteoclast ef-
fectively so that there is no excessive bone resorption in
osteogenesis or bone remodeling after the surgery men-
tioned in our work. Therefore, ECT could not only de-
crease the bone resorption but also slightly promote the
ossification in the first 4 weeks after surgery.
Additionally, based on radiological, BMD, and histomor-
phometric evaluation of proximal tibia away from fractured
femur without immobilization from 8 to 12 weeks in rats
treated with ECT, we concluded that ECT might still
sustain the osteogenic process and at least had no negative
effect on the intrinsic properties of femurs and tibias.
There are several limitations in the current study.
Firstly, it is an exclusively in vivo experiment for prophy-
lactic and therapeutical effects of ECT on the surgically-
induced DOP in animal models. In addition, a limited
number of time points prohibited a more detailed obser-
vation of the stages of DOP and the ideal time for ad-
ministration of ECT. Finally, anti-resorptive agents are
generally administrated for elderly patients with osteopor-
osis clinically, and the animal models should provide
clinically related information. Therefore, the elderly ani-
mals should be utilized to further elucidate a more
complete understanding of the effect of ECT on the
DOP after the fracture fixation in the future.
Conclusion
The present study highlights that elcatonin can attenuate
surgically induced bone loss and deterioration of tra-
beculae in the distal bone from fracture in rats, which
may serve as an alternative medicine for the prophylaxis
and treatment of disuse osteoporosis after surgery in
clinic practice. In the future study, the molecular mecha-
nisms of related protein and cytokine regulation behind
the results and examinations need further investigation.
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